- Home
- RGEN vs EVR Comparison
RGEN vs EVR Comparison
Compare RGEN & EVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGEN
- EVR
- Stock Information
- Founded
- RGEN 1981
- EVR 1995
- Country
- RGEN United States
- EVR United States
- Employees
- RGEN N/A
- EVR N/A
- Industry
- RGEN Medical/Dental Instruments
- EVR Investment Managers
- Sector
- RGEN Health Care
- EVR Finance
- Exchange
- RGEN Nasdaq
- EVR Nasdaq
- Market Cap
- RGEN 8.2B
- EVR 8.6B
- IPO Year
- RGEN N/A
- EVR 2006
- Fundamental
- Price
- RGEN $144.74
- EVR $236.15
- Analyst Decision
- RGEN Buy
- EVR Hold
- Analyst Count
- RGEN 10
- EVR 6
- Target Price
- RGEN $188.38
- EVR $242.20
- AVG Volume (30 Days)
- RGEN 871.2K
- EVR 187.6K
- Earning Date
- RGEN 10-29-2024
- EVR 10-23-2024
- Dividend Yield
- RGEN N/A
- EVR 1.33%
- EPS Growth
- RGEN N/A
- EVR N/A
- EPS
- RGEN N/A
- EVR 7.24
- Revenue
- RGEN $602,354,000.00
- EVR $2,624,426,000.00
- Revenue This Year
- RGEN $0.08
- EVR $22.47
- Revenue Next Year
- RGEN $12.97
- EVR $19.45
- P/E Ratio
- RGEN N/A
- EVR $32.32
- Revenue Growth
- RGEN N/A
- EVR 5.83
- 52 Week Low
- RGEN $110.45
- EVR $124.53
- 52 Week High
- RGEN $211.13
- EVR $254.74
- Technical
- Relative Strength Index (RSI)
- RGEN 45.74
- EVR 48.49
- Support Level
- RGEN $139.41
- EVR $233.11
- Resistance Level
- RGEN $150.72
- EVR $241.69
- Average True Range (ATR)
- RGEN 5.10
- EVR 4.55
- MACD
- RGEN -1.06
- EVR -1.19
- Stochastic Oscillator
- RGEN 36.99
- EVR 20.33
About RGEN Repligen Corporation
Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America.
About EVR Evercore Inc.
Evercore is an independent investment bank that derives the majority of its revenue from financial advisory, including merger, acquisition, and restructuring advisory. It also has institutional equities trading, equity underwriting, and investment management businesses that account for around 20% of net revenue. The company was founded in 1996 and went public in 2006. Evercore had approximately 2,200 employees at the end of 2023, and about 75% of its revenue is derived from the United States.